Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 4 results

Name	Type of Offering	Accepted Date
Equilibre BioPharmaceuticals Corp. See All Filings	D/A	2022-12-01 14:30:25 UTC
Amount To Be Raised $6,000,002 Associated Brokers / Dealers N/A CIK Number 0001831900 Filed Document 0001831900-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-12-01 14:30:25 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings	D	2022-11-30 21:31:34 UTC
Amount To Be Raised $6,000,002 Associated Brokers / Dealers N/A CIK Number 0001831900 Filed Document 0001831900-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-11-30 21:31:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings	D	2022-01-20 14:25:36 UTC
Amount To Be Raised $25,000,000 Associated Brokers / Dealers N/A CIK Number 0001831900 Filed Document 0000947871-22-000085 Exclusions or Exemptions 506b Accepted Date 2022-01-20 14:25:36 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
Equilibre BioPharmaceuticals Corp. See All Filings	D	2020-11-12 12:10:33 UTC
Amount To Be Raised $35,799,973 Associated Brokers / Dealers N/A CIK Number 0001831900 Filed Document 0001831900-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-11-12 12:10:33 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity